出血性胃炎的临床治疗方案分析与疗效观察

Clinical Treatment Analysis and Clinical Observation of Hemorrhagic Gastritis

目的:探究出血性胃炎的临床治疗方案及效果。方法:将2012年9月至2014年12月期间收治的80例出血性胃炎患者随机分为观察组及对照组,每组40例,对照组给予单纯奥美拉唑治疗,观察组在此基础上运用硫糖铝,比较两组临床疗效、住院治疗时间、复发率。结果:观察组治疗总临床治疗有效率为95.0%,显著高于对照组(77.5%);观察组患者平均住院治疗时间为(7.13±2.05)d,对照组为(13.25±3.51)d,两组比较差异具有统计学意义(P<0.05);观察组复发率为2.5%,对照组为17.5%,差异具有统计学意义(P<0.05)。结论:采用奥美拉唑联合硫糖铝治疗出血性胃炎,临床治疗效果明显,复发率低,并显著减少患者住院治疗时间,减轻患者负担。

Objective:To explore the clinical treatment plan and effect of hemorrhagic gastritis.Methods:It will be treated from Sep 2012 to Dec 2014 during the 80 cases of hemorrhagic gastritis were divided randomly observation into group control and group 40 cases,control group received omeprazole alone treatment,observation group on the basis of use sucralfate,comparative clinical efficacy,hospitalization,relapse rate.Results:Clinical observation group total effective rate was 95.0%,significantly higher(77.5%);the observation group were hospitalized an average time of(7.13±2.05) d,the control group(13.25±3.51) d,the difference was statistically significant(P<0.05);recurrence rate was 2.5%in the observation group,the control group was 17.5%,the was difference significant statistically(P<0.05).Conclusion:With the omeprazole combined with sucralfate in the treatment of hemorrhagic gastritis,obvious curative effect,low recurrence rate,and significantly reduce hospitalization time,reduce the burden of the patients.